<div dir="ltr"><p class="MsoNormal" style="margin:0px;text-align:left;color:rgb(34,34,34);text-transform:none;text-indent:0px;letter-spacing:normal;font-size:16px;font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;word-spacing:0px;white-space:normal;background-color:transparent">Thank you for all the welcome messages as I am new to the group! I wanted to share the following message from Ron Andruff regarding the ICANN 3-person Standing Panel unanimously affirming Canada Wide Pharmacy's PICDRP filing again NABP and .Pharmacy as we believe this is an important issue.</p><p class="MsoNormal" style="margin:0px;text-align:left;color:rgb(34,34,34);text-transform:none;text-indent:0px;letter-spacing:normal;font-size:16px;font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;word-spacing:0px;white-space:normal;background-color:transparent"><br>Message from Ron Andruff: <br></p><p class="MsoNormal" style="margin:0px;text-align:left;color:rgb(34,34,34);text-transform:none;text-indent:0px;letter-spacing:normal;font-size:16px;font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;word-spacing:0px;white-space:normal;background-color:transparent"><br></p><p class="MsoNormal" style="margin:0px;text-align:left;color:rgb(34,34,34);text-transform:none;text-indent:0px;letter-spacing:normal;font-size:16px;font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;word-spacing:0px;white-space:normal;background-color:transparent"><span>Over the course of the last several years Tim Smith of the Canadian International Pharmacy Association (CIPA) and I have shared with you and others in the ICANN community our concerns about the National Association of Boards of Pharmacy (NABP) discriminatory .Pharmacy Registry policies.<u></u><u></u></span></p><p class="MsoNormal" style="margin:0px;text-align:left;color:rgb(34,34,34);text-transform:none;text-indent:0px;letter-spacing:normal;font-size:16px;font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;word-spacing:0px;white-space:normal;background-color:transparent"><span style="font-family:SourceSansPro-Regular"><u></u> <u></u></span></p><p class="MsoNormal" style="margin:0px;text-align:left;color:rgb(34,34,34);text-transform:none;text-indent:0px;letter-spacing:normal;font-size:16px;font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;word-spacing:0px;white-space:normal;background-color:transparent"><span>On July 12^th, the ICANN appointed, 3-person Standing Panel – citing three inconsistencies in the registration policies – unanimously affirmed Canada Wide Pharmacy’s PICDRP filing against NABP and .Pharmacy noting </span><span style="font-family:SourceSansPro-Regular">that “<i>the Registry Operator did not comply with its obligations under the PIC to operate .Pharmacy applications in a transparent manner</i>”, neither did they “<i>implement clear registration policies and program standards</i>”.<u></u><u></u></span></p><p class="MsoNormal" style="margin:0px;text-align:left;color:rgb(34,34,34);text-transform:none;text-indent:0px;letter-spacing:normal;font-size:16px;font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;word-spacing:0px;white-space:normal;background-color:transparent"><span style="font-family:SourceSansPro-Regular"><u></u> <u></u></span></p><p class="MsoNormal" style="margin:0px;text-align:left;color:rgb(34,34,34);text-transform:none;text-indent:0px;letter-spacing:normal;font-size:16px;font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;word-spacing:0px;white-space:normal;background-color:transparent"><span style="font-family:SourceSansPro-Regular">Paragraph 3(c) of Specification 11 reads as follows:  “<i>Registry Operator will operate the TLD in a transparent manner consistent with general principles of openness and non-discrimination by establishing, publishing and adhering to clear registration policies</i>”.<u></u><u></u></span></p><p class="MsoNormal" style="margin:0px;text-align:left;color:rgb(34,34,34);text-transform:none;text-indent:0px;letter-spacing:normal;font-size:16px;font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;word-spacing:0px;white-space:normal;background-color:transparent"><span><u></u> <u></u></span></p><p class="MsoNormal" style="margin:0px;text-align:left;color:rgb(34,34,34);text-transform:none;text-indent:0px;letter-spacing:normal;font-size:16px;font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;word-spacing:0px;white-space:normal;background-color:transparent"><span>We are alerting you to this important news to specifically point out a real-world example of the many policy deficiencies that we have spoken with you about, and which continue to plague the .Pharmacy registry. <u></u><u></u></span></p><p class="MsoNormal" style="margin:0px;text-align:left;color:rgb(34,34,34);text-transform:none;text-indent:0px;letter-spacing:normal;font-size:16px;font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;word-spacing:0px;white-space:normal;background-color:transparent"><span style="font-family:SourceSansPro-Regular"><u></u> <u></u></span></p><p class="MsoNormal" style="margin:0px;text-align:left;color:rgb(34,34,34);text-transform:none;text-indent:0px;letter-spacing:normal;font-size:16px;font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;word-spacing:0px;white-space:normal;background-color:transparent"><span style="font-family:SourceSansPro-Regular">ICANN has called upon NABP and .</span><span>Pharmacy to comply with the Standing Panel’s assessment and cure two registry contract breaches before August 11^th, 2018 or ICANN may commence a termination process.<u></u><u></u></span></p><p class="MsoNormal" style="margin:0px;text-align:left;color:rgb(34,34,34);text-transform:none;text-indent:0px;letter-spacing:normal;font-size:16px;font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;word-spacing:0px;white-space:normal;background-color:transparent"><span><u></u> <u></u></span></p><p class="MsoNormal" style="margin:0px;text-align:left;color:rgb(34,34,34);text-transform:none;text-indent:0px;letter-spacing:normal;font-size:16px;font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;word-spacing:0px;white-space:normal;background-color:transparent"><span>From a media perspective, </span><a style="color:rgb(17,85,204)" href="https://domainnamewire.com/2018/07/13/icann-puts-pharmacy-operator-national-association-of-board-of-pharmacy-on-notice/" target="_blank"><span>this article</span></a><span> captures the matter very well.<u></u><u></u></span></p><p class="MsoNormal" style="margin:0px;text-align:left;color:rgb(34,34,34);text-transform:none;text-indent:0px;letter-spacing:normal;font-size:16px;font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;word-spacing:0px;white-space:normal;background-color:transparent"><span><u></u> <u></u></span></p><p class="MsoNormal" style="margin:0px;text-align:left;color:rgb(34,34,34);text-transform:none;text-indent:0px;letter-spacing:normal;font-size:16px;font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;word-spacing:0px;white-space:normal;background-color:transparent"><span>Thank you for your continued interest in our labors to bring positive changes to .Pharmacy in our effort to ensure that one day this industry-specific registry will truly be as the ICANN community intended: A global resource for licensed pharmacies all over the world for the good of all concerned; rather than be used solely by Big Pharma for shadow regulation, as it is today.<u></u><u></u></span></p><p class="MsoNormal" style="margin:0px;text-align:left;color:rgb(34,34,34);text-transform:none;text-indent:0px;letter-spacing:normal;font-size:16px;font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;word-spacing:0px;white-space:normal;background-color:transparent"><span><u></u> <u></u></span></p><p class="MsoNormal" style="margin:0px;text-align:left;color:rgb(34,34,34);text-transform:none;text-indent:0px;letter-spacing:normal;font-size:16px;font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;word-spacing:0px;white-space:normal;background-color:transparent"><span>As always, we welcome your thoughts, questions or comments on this matter.  </span></p><p class="MsoNormal" style="margin:0px;text-align:left;color:rgb(34,34,34);text-transform:none;text-indent:0px;letter-spacing:normal;font-size:16px;font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;word-spacing:0px;white-space:normal;background-color:transparent"><span><br></span></p><p class="MsoNormal" style="margin:0px;text-align:left;color:rgb(34,34,34);text-transform:none;text-indent:0px;letter-spacing:normal;font-size:16px;font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;word-spacing:0px;white-space:normal;background-color:transparent"><span>Thank you - </span></p><p class="MsoNormal" style="margin:0px;text-align:left;color:rgb(34,34,34);text-transform:none;text-indent:0px;letter-spacing:normal;font-size:16px;font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;word-spacing:0px;white-space:normal;background-color:transparent"><span><br></span></p><p class="MsoNormal" style="margin:0px;text-align:left;color:rgb(34,34,34);text-transform:none;text-indent:0px;letter-spacing:normal;font-size:16px;font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;word-spacing:0px;white-space:normal;background-color:transparent"><span><u></u> <u></u></span></p><p class="MsoNormal" style="margin:0px;text-align:left;color:rgb(34,34,34);text-transform:none;text-indent:0px;letter-spacing:normal;font-size:16px;font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;word-spacing:0px;white-space:normal;background-color:transparent"><br></p></div>